Table 6

‚ÄÉNumber of patients needed to treat during one year to prevent one adverse event

Number needed to treat (95% confidence interval)
In-stent restenosisIn-segment restenosisTLRMACE
*95% confidence interval includes benefit and harm (number of patients needed to treat to prevent one event (NNTB); number of patients needed to treat to harm one patient (NNTH)).34
Sirolimus eluting stent
Patients without diabetes2.4 (2.3 to 2.6)2.6 (2.5 to 2.9)6.5 (5.9 to 7.6)6.2 (5.3 to 8.0)
Patients with diabetes1.6 (1.5 to 1.9)1.9 (1.7 to 2.3)5.5 (4.8 to 7.3)4.0 (3.4 to 5.5)
Paclitaxel eluting stent
Patients without diabetes3.2 (2.8 to 3.9)3.3 (2.9 to 4.0)8.1 (7.0 to 10.1)16.7 (NNTB 7.7 to NNTH 18.2)*
Patients with diabetes1.7 (1.5 to 2.3)1.7 (1.5 to 2.2)5.8 (4.9 to 9.1)6.0 (NNTB 3.4 to NNTH 6.3)*